The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Abstract
Cirrhosis and other chronic liver diseases (collectively referred to as cirrhosis in this paper) are a major cause of morbidity and mortality globally, although the burden and underlying causes differ across locations and demographic groups. We report on results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 on the burden of cirrhosis and its trends since 1990, by cause, sex, and age, for 195 countries and territories.
We used data from vital registrations, vital registration samples, and verbal autopsies to estimate mortality. We modelled prevalence of total, compensated, and decompensated cirrhosis on the basis of hospital and claims data. Disability-adjusted life-years (DALYs) were calculated as the sum of years of life lost due to premature death and years lived with disability. Estimates are presented as numbers and age-standardised or age-specific rates per 100 000 population, with 95% uncertainty intervals (UIs). All estimates are presented for five causes of cirrhosis: hepatitis B, hepatitis C, alcohol-related liver disease, non-alcoholic steatohepatitis (NASH), and other causes. We compared mortality, prevalence, and DALY estimates with those expected according to the Socio-demographic Index (SDI) as a proxy for the development status of regions and countries.
Citation impact
- FWCI
- 120.25
- Percentile
- 100%
- References
- 49
Authors
202Topics & keywords
- Medicine
- Cirrhosis
- Demography
- Population
- Disease burden
- Proxy (statistics)
- Mortality rate
- Alcoholic liver disease
- Good health and well-being
Funding
- UDU.S. Department of Veterans Affairs
- BABill and Melinda Gates Foundation
- SSanofi
- IDInter-American Development Bank
- OOOrganization of American States
- KPKaiser Permanente
- UNUnited Nations Population Fund
- WTWellcome Trust
- PHPublic Health Agency of CanadaAwards: UID/MULTI/04378/2019, UID/QUI/50006/2019
- UDUniversità degli Studi di Milano
- AUAksum University
- MUMaragheh University of Medical Sciences
- UOUniversity of Warwick
- UCUniversity College London
- DODepartment of Biotechnology, Ministry of Science and Technology, India
- PHPublic Health Agency
- MUMonash University
- BFBundesministerium für Bildung und ForschungAward: 01EA1808A
- CUCairo University
- CNConsejo Nacional de Ciencia y Tecnología
- MOMinistry of Health and Medical Education
- MUMazandaran University of Medical Sciences
- UOUniversity of Waterloo
- UFUniversidade Federal do Rio Grande do Sul
- UBUniversität Bielefeld
- MDMinistério da Ciência, Tecnologia e Ensino SuperiorAwards: SFRH/BHD/110001/2015, UID/QUI/50006/2019, DL57/2016
- UDUniversidade do Porto
- AAAddis Ababa University
- XUXiamen University
- UOUniversity of Peradeniya
- TWThe Wellcome Trust DBT India AllianceAward: IA/CPHI/14/1/501497
- CNConsejo Nacional para Investigaciones Científicas y Tecnológicas
- AMApplied Molecular Biosciences UnitAward: DL57/2016
- RDRede de Química e TecnologiaAward: UID/QUI/50006/2019
- LALaboratório Associado para a Química VerdeAward: UID/QUI/50006/2019
- SPSanofi Pasteur
- ĐHĐại học Quốc gia Hà Nội
- MRMedical Research CouncilAward: MR/M015084/1
- FPFundação para a Ciência e a TecnologiaAwards: SFRH/BHD/110001/2015, DL57/2016/CP1334/CT0006, DL57/2016, UID/QUI/50006/2019, UID/QUI/50006
- DDDipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca
- NCNational Cancer Institute
- IOInstitute of Infection and Immunity